Response to letter: “The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI and receiving abciximab”
Cardiology Journal · 05.02.2026 · 33
DOI: 10.5603/cj.109788 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cardiology Journal, online erschienen am 05.02.2026. Verfasst von Onur Altınkaya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Erzurum City Hospital, Erzurum, Turkey. onuraltinkaya35@gmail.com. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Erzurum City Hospital, Erzurum, Turkey. onuraltinkaya35@gmail.com.
- Erzurum City Hospital, Erzurum, Turkey.
ORCID-Profile: Onur Altınkaya, Selim Aydemir, Mustafa Özkoç
Zitieren
APA
Altınkaya, O., Aydemir, S., & Özkoç, M. (2026). Response to letter: “The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI and receiving abciximab”. Cardiology Journal, 33(0). https://doi.org/10.5603/cj.109788
Vancouver
Altınkaya O, Aydemir S, Özkoç M. Response to letter: “The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI and receiving abciximab”. Cardiology Journal. 2026;33(0). doi:10.5603/cj.109788
BibTeX
@article{Altnkaya2026,
author = {Altınkaya, Onur and Aydemir, Selim and Özkoç, Mustafa},
title = {Response to letter: “The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI and receiving abciximab”},
journal = {Cardiology Journal},
year = {2026},
volume = {33},
number = {0},
doi = {10.5603/cj.109788}
}
EUVIMED